Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	IDXXIdexx Laboratories	BDXBecton Dickinson	EWEdwards Lifesciences
Snapshot
Price	$596.54	$176.48	$90.03
Market cap	$44.00B	$43.56B	$54.34B
Valuation
P/E	43x	42.9x	47.2x
Forward P/E	34.2x	57.1x	67.5x
Growth
Revenue growth	13.1%	2.4%	13.8%
EPS growth	25.6%	-24.8%	-73.2%
Profitability
Net margin	24.6%	5.3%	17.4%
ROE	70.9%	4.5%	10.6%
Balance sheet & cash
Debt / equity	0.53x	0.76x	0.06x
Free cash flow yield	1.9%	9.0%	2.9%
Dividend yield	—	2.9%	—
Verdict
Investment rating	Favorable· 65	Weak· 32	Neutral· 47

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	IDXXtoday $597	BDXtoday $176	EWtoday $90
2027	$561.90 – $824.11+38% CAGR	$135.01 – $198.01+12% CAGR	$68.87 – $101.01+12% CAGR
2028	$705.69 – $1,035.00+32% CAGR	$137.71 – $201.97+7% CAGR	$70.25 – $103.03+7% CAGR
2029	$886.27 – $1,299.86+30% CAGR	$140.46 – $206.01+5% CAGR	$71.66 – $105.09+5% CAGR
2030	$1,113.07 – $1,632.50+29% CAGR	$143.27 – $210.13+4% CAGR	$73.09 – $107.20+4% CAGR
2031	$1,397.90 – $2,050.25+28% CAGR	$146.14 – $214.33+4% CAGR	$74.55 – $109.34+4% CAGR
5-yr CAGR	18.6% – 28.0%	-3.7% – 4.0%	-3.7% – 4.0%